Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma

Faron Pharmaceuticals Ltd · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
carcinoma
carcinoma, renal cell, carcinoma colon, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 866150
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.